ISpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers
ISpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers
Woburn, Massachusetts--(Newsfile Corp. - December 13, 2024) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today positive results attributed to its Next Day Quote Program ("NDQ"). This next-day quote service for researchers and providers is tailored to accelerate the biospecimen transaction process and delivers accurate biospecimen sample pricing within 24 hours of receiving the customer request. Next Day Quotes are possible to implement only when the Company knows the supplier's data on their specific capabilities and pricing, as well as understands the customer's requirements.
马萨诸塞州沃本--(Newsfile Corp. - 2024年12月13日) - iSpecimen Inc.(纳斯达克:ISPC)(“iSpecimen”或“公司”)是一个在线全球市场,连接需要用于医疗研究的生物样本的科学家与医疗样本提供者网络,今天宣布其次日报价计划(“NDQ”)取得了积极的成果。该次日报价服务为研究人员和提供者量身定制,以加快生物样本交易过程,并在收到客户请求后的24小时内提供准确的生物样本定价。次日报价的实施只有在公司了解供应商在其特定能力和定价方面的数据,并理解客户的要求时才有可能。
Recognizing the need for timely access to high-quality biospecimens to advance life science research, iSpecimen had introduced NDQ to offer researchers and providers with swift and accurate sample pricing. From fresh whole blood and prescreened mutation-characterized blocks to an array of clinically collected remnant, banked and prospective biospecimens, most quotes are provided within a day of receiving the inquiry.
iSpecimen认识到及时获取高质量生物样本以推动生命科学研究的必要性,推出了NDQ,为研究人员和提供者提供快速且准确的样本定价。从新鲜全血和预筛选的突变特征块到多种临床收集的剩余、储存和前瞻性生物样本,大多数报价在收到询问后的一天内提供。
Since introducing the program in 2023 and the recently completed build of a search tool, quotes can be created within minutes. With this capability, the Company's sales mix has increasingly shifted towards NDQ. In November 2024, 30% of all sales opportunities were Next Day Quotes. Of all quotes that were generated in November 2024, 48% were Next Day Quotes. Meanwhile, the conversion rate was high for Next Day Quotes. 60% of all purchase orders were Next Day Quotes1.
自2023年推出该计划和最近完成搜索工具的建设以来,报价可以在几分钟内创建。凭借这一能力,公司的销售组合越来越向NDQ倾斜。在2024年11月,所有销售机会中有30%是次日报价。在2024年11月生成的所有报价中,有48%是次日报价。同时,次日报价的转化率很高,60%的所有采购订单是次日报价。
Leslie Hoyt, Senior Vice President of Operations commented, "Our customers have responded enthusiastically to iSpecimen's Next Day Quote Program. For the first six months of the program, NDQ has consistently yielded strong results, driving an estimated 60% of sales. The data continue to show that if we quote within the next business day, we greatly increase the likelihood of receiving a signed purchase order. Current and future customers respond positively because time matters."
运营高级副总裁Leslie Hoyt评论道:“我们的客户对iSpecimen的次日报价计划反应热烈。在该计划的前六个月,NDQ始终取得良好的成果,推动了约60%的销量。数据继续表明,如果我们在下一个工作日内报价,我们会大大增加收到签署采购订单的可能性。当前和未来的客户积极响应,因为时间很重要。”
Ms. Hoyt further commented, "We continue to enhance our internal databases and search tools to proactively harvest data, ensuring the viability of Next day Quote program while increasing the frequency with which Next Day Quotes are possible. This offering accelerates our operational timeline and the customer decision journey. Ultimately next day quotes allow researchers and providers to focus on what matters most, and iSpecimen to be a valuable service provider for all customers."
霍伊特女士进一步评论道:"我们继续增强我们的内部数据库和搜索工具,以主动收集数据,确保次日报价计划的可行性,同时增加次日报价的频率。此产品加快了我们的运营时间线和客户决策过程。最终,次日报价使研究人员和供应商能够专注于最重要的事情,也使iSpecimen成为所有客户的有价值服务提供者。"
About iSpecimen
iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit .
关于iSpecimen
iSpecimen(纳斯达克:ISPC)提供一个在线市场,用于人类生物样本,连接商业和非营利组织的科学家与能够接触所需患者和样本的医疗保健提供者。专有的基于云的科技使科学家能够直观地在医院、实验室、生物材料库、献血中心以及其他医疗组织的联邦合作伙伴网络中搜索样本和患者。欲了解更多信息,请访问。
Forward Looking Statements
前瞻性声明
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as "may," "will," "expect," "intend," "anticipate," "believe," "estimate" and "continue" or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the risk factors contained in the Company's filings with the SEC, which are available for review at www.sec.gov. Forward-looking statements speak only as of the date they are made. New risks and uncertainties arise over time, and it is not possible for the Company to predict those events or how they may affect the Company. If a change to the events and circumstances reflected in the Company's forward-looking statements occurs, the Company's business, financial condition and operating results may vary materially from those expressed in the Company's forward-looking statements. Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
本新闻稿可能包含根据《1933年证券法》第27A节及《1934年证券交易法》第21E节(经修订)定义的前瞻性陈述。这些前瞻性陈述使用了“可能”、“将”、“期望”、“打算”、“预期”、“相信”、“估计”和“继续”或类似词汇的未来或条件动词。您应仔细阅读包含这些词的陈述,因为它们讨论未来期望和计划,包括未来经营结果或财务状况的预测或其他前瞻性信息。前瞻性陈述是基于当前期望和假设,对未来事件的预测、规划及其他陈述,因此受风险和不确定性的影响。许多因素可能使实际未来事件与本新闻稿中的前瞻性陈述有显著不同,包括但不限于公司向美国证券交易委员会(SEC)提交的文件中包含的风险因素,这些文件可在www.sec.gov上查阅。前瞻性陈述仅在发表之日有效。新的风险和不确定性会随时间而出现,因此公司无法预测这些事件及其可能对公司的影响。如果公司前瞻性陈述反映的事件和情况发生变化,公司的业务、财务状况和经营结果可能与公司前瞻性陈述中表达的内容有实质性差异。提醒读者不要对前瞻性陈述过度依赖,公司不承担任何义务,且不打算更新或修订这些前瞻性陈述,无论是由于新信息、未来事件或其他原因。
For further information, please contact:
Investor Contacts
info@ispecimen.com
如需更多信息,请联系:
投资者联系方式
info@ispecimen.com
_________________________
1 Source: Company analysis using data from internal business analytics and CRM platforms.
_________________________
1 来源:公司分析使用内部业务分析和客户关系管理平台的数据。